New sunscreen aims to stop precancerous skin lesions in their tracks

NCT ID NCT07335003

Recruiting now Prevention Sponsor: Cosmetique Active International Source: ClinicalTrials.gov ↗

First seen Jan 12, 2026 · Last updated May 20, 2026 · Updated 25 times

Summary

This study tests whether a new sunscreen, Anthelios Fluide 100 KA+ UVMune 400, can prevent actinic keratosis (AK) — rough, scaly precancerous spots caused by sun damage — in adults aged 60 and older who already have multiple AKs. Eighty participants will be randomly assigned to use the sunscreen with good sun habits or continue their usual sun protection. The main goal is to see if the sunscreen reduces the number of new AK lesions over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSIS (AK) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital
RECRUITING

Camperdown, New South Wales, 2050, Australia

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ACTINIC KERATOSIS (AK)